Literature DB >> 7684750

Identification of specific antigens of Pseudomonas pseudomallei and evaluation of their efficacies for diagnosis of melioidosis.

N Anuntagool1, P Rugdech, S Sirisinha.   

Abstract

Current methods for the diagnosis of melioidosis are based on bacteriological culture. A number of serological tests currently available lack specificity and sensitivity. This is largely due to the use of crude antigens which results in a significant cross-reactivity with sera from individuals infected with other bacteria. In this study five different antigens were prepared and evaluated for their potential usefulness in diagnosis of melioidosis. These included a 19.5-kDa antigen which was previously shown to be specific by Western blotting (immunoblotting), a crude cell extract, a veronal extract, a 39.0-kDa antigen, and an immunoaffinity-purified antigen. All antigens were used for detecting antibody in sera from patients with septicemic melioidosis by indirect enzyme-linked immunosorbent assay. The results were compared with those obtained with sera from patients with other bacterial infections and normal sera from areas where the infection is and is not endemic. The 19.5-kDa antigen exhibited the most satisfactory results, with 92% sensitivity, 91% specificity, 81% positive predictive value, and 96% negative predictive value based on a background obtained with normal sera from the area where the infection is nonendemic. These values were 82% sensitivity, 96% specificity, 94% positive predictive value, and 87% negative predictive value based on results with normal sera from the area where the infection is endemic. Results from this study showed that the 19.5-kDa antigen was potentially useful in the diagnosis of melioidosis and deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684750      PMCID: PMC262909          DOI: 10.1128/jcm.31.5.1232-1236.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Enzyme-linked immunosorbent assay for immunoglobulin M specific antibody for the diagnosis of melioidosis.

Authors:  M Kunakorn; P Boonma; K Khupulsup; B Petchclai
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Diagnostic value of the indirect hemagglutination test for melioidosis in an endemic area.

Authors:  H Appassakij; K R Silpapojakul; R Wansit; M Pornpatkul
Journal:  Am J Trop Med Hyg       Date:  1990-03       Impact factor: 2.345

4.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

5.  Application of indirect hemagglutination test and indirect fluorescent antibody test for IgM antibody for diagnosis of melioidosis in Thailand.

Authors:  K Khupulsup; B Petchclai
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

6.  Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests.

Authors:  A D Alexander; D L Huxsoll; A R Warner; V Shepler; A Dorsey
Journal:  Appl Microbiol       Date:  1970-11

7.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

Authors:  M J Thomassen; C A Demko; J D Klinger; R C Stern
Journal:  Am Rev Respir Dis       Date:  1985-05

8.  Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis.

Authors:  L R Ashdown; R W Johnson; J M Koehler; C A Cooney
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

9.  Enzyme-linked immunosorbent assay for detection of antibody to Gnathostoma antigen in patients with intermittent cutaneous migratory swelling.

Authors:  A Dharmkrong-at; S Migasena; P Suntharasamai; D Bunnag; R Priwan; S Sirisinha
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

10.  Relationship and significance of specific immunoglobulin M antibody response in clinical and subclinical melioidosis.

Authors:  L R Ashdown
Journal:  J Clin Microbiol       Date:  1981-10       Impact factor: 5.948

View more
  6 in total

1.  Recombinant truncated flagellin of Burkholderia pseudomallei as a molecular probe for diagnosis of melioidosis.

Authors:  Yao-Shen Chen; David Shiuan; Ssu-Ching Chen; Soi-Moi Chye; Ya-Lei Chen
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

2.  Detection of Burkholderia pseudomallei DNA in patients with septicemic melioidosis.

Authors:  T Dharakul; S Songsivilai; S Viriyachitra; V Luangwedchakarn; B Tassaneetritap; W Chaowagul
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection.

Authors:  A Anuntagool; P Intachote; P Naigowit; S Sirisinha
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Evaluation of immunoglobulin M (IgM) and IgG rapid cassette test kits for diagnosis of melioidosis in an area of endemicity.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Wirongrong Chierakul; Allen C Cheng; Nicholas J White; Sharon J Peacock; Nicholas P J Day
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

6.  Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.

Authors:  Vichaya Suttisunhakul; Vanaporn Wuthiekanun; Paul J Brett; Srisin Khusmith; Nicholas P J Day; Mary N Burtnick; Direk Limmathurotsakul; Narisara Chantratita
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.